Abbott Laboratories (ABT) Stock Price & Analysis
Abbott Laboratories (ABT) fell 0.42% to USD 108.33 as of September 8, 2026 at 02:51 UTC, according to Nexqual real-time market data.
ABT last closed at USD 108.33; the session ranged USD 107.36–110.01 on volume of 6,880,590 shares. Market capitalization is —, with a 52-week range of USD 81.97–137.49 (NYQ). Source: Nexqual, September 8, 2026 at 02:51 UTC.
Key Statistics (as of September 8, 2026 at 02:51 UTC)
| Price | USD 108.33 |
|---|---|
| Change | ▼ 0.42% (down) |
| Previous Close | USD 108.33 |
| Open | USD 108.33 |
| Day Range | USD 107.36 – 110.01 |
| 52-Week Range | USD 81.97 – 137.49 |
| Volume | 6,880,590 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ABT)
Nexqual's technical model rates ABT "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 02:51 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 48.26 (neutral) |
| vs SMA50 | Above (USD 104.37) |
| MACD | 1.35 (positive) |
From Abbott Laboratories's Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Department of Health and Human Services has issued rules governing the use, disclosure, and security of protected health information, and the FDA has issued further guidance concerning cybersecurity for medical devices.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABBV | AbbVie Inc. | USD 256.46 | ▼ 2.01% |
| BMY | Bristol-Myers Squibb Company | USD 66.82 | ▼ 1.24% |
| JNJ | Johnson & Johnson | USD 275.23 | ▲ 0.01% |
| MDT | Medtronic plc. | USD 94.17 | ▲ 2.16% |
| LLY | Eli Lilly and Company | USD 1,149.36 | ▼ 0.92% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:51 UTC. This page is informational and not investment advice.